Active ingredient
Misoprostol
26 finished FDA listings contain Misoprostol as their only active ingredient; 26 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- MISOPROSTOL
- Dosage forms
- Liquid, Tablet
- Routes
- Oral, Topical
- Manufacturers / labelers
- 17
- Strengths listed
- 10 g/100ml · 100 ug/1 · 200 ug/1
- Brand names in FDA listings
- Cytotec, Tobcharm Toenail Fungus Treatment Liquid
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 42331
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 019268 | PFIZER | 1988-12-27 | 6 |
| ANDA 076095 | ANI PHARMS | 2002-07-10 | 10 |
| ANDA 091667 | NOVEL LABS INC | 2012-07-25 | 6 |
| ANDA 210201 | ACQ PHARMA | 2019-07-02 | 3 |
Official labeling on DailyMed
- MISOPROSTOL TABLET [MYLAN PHARMACEUTICALS INC.] · version 16 · 2026-08-27
- MISOPROSTOL TABLET [BRYANT RANCH PREPACK] · version 102 · 2026-07-01
- MISOPROSTOL TABLET [AMERICAN HEALTH PACKAGING] · version 3 · 2026-06-26
- MISOPROSTOL TABLET [GENBIOPRO, INC.] · version 3 · 2026-06-10
- CYTOTEC (MISOPROSTOL) TABLET [PFIZER LABORATORIES DIV PFIZER INC] · version 22 · 2026-06-05
- MISOPROSTOL TABLET [BRYANT RANCH PREPACK] · version 101 · 2026-05-13
- MISOPROSTOL TABLET [PD-RX PHARMACEUTICALS, INC.] · version 9 · 2026-02-27
- MISOPROSTOL TABLET [AVPAK] · version 2 · 2026-01-12
- MISOPROSTOL TABLET [REDPHARM DRUG] · version 3 · 2025-12-29
- TOBCHARM TOENAIL FUNGUS TREATMENT LIQUID (TOENAIL FUNGUS TREATMENT LIQUID) LIQUID [GUANGZHOU QIEXIRAN COSMETICS CO., LTD.] · version 1 · 2025-12-16
- MISOPROSTOL TABLET [ANI PHARMACEUTICALS, INC.] · version 4 · 2025-11-17
- MISOPROSTOL TABLET [NUCARE PHARMACEUTICALS, INC.] · version 2 · 2025-01-16
Showing the 12 most recent of 19 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.